2020 Annual Update in Medical Hepatology
Join the UPMC Center for Liver Diseases for an online, accredited educational program to learn more about current trends, management techniques, recent innovations, and research to treat a full range of liver diseases. Our experts will present updates on various topics, including the treatment of alcoholic liver disease and nonalcoholic fatty liver disease, liver cancer, liver transplantation, autoimmune treatment advancements, and ramifications of the COVID-19 pandemic on liver treatment modalities.
Course Format
The 2020 Annual Update in Medical Hepatology will be held exclusively online. To register or to attend the conference, visit UPMC.com/CenterForLiverDiseases. The audience will have the opportunity to ask questions at the end of each presentation.
Target Audience
This course is designed for experts in hepatology, gastroenterology, and abdominal and general surgery, referring primary care physicians, and other health care professionals with an interest in the treatment and latest research for liver disease.
Learning Objectives
- Partner with other regional academic liver programs and regional nonprofit collaborators to educate the regional medical community about liver disease advancements.
- Identify advancements in non-alcoholic and alcoholic liver disease treatments, with attention to liver diseases such as NAFLD, cholestatic diseases, and hepatocellular carcinoma.
- Examine current efforts toward hepatitis C elimination.
- Address barriers to liver transplantation and living-donor liver transplant, leading to enhanced patient care.
- Foster the development of multidisciplinary, fluid and interactive models to treat liver diseases.
Additional Information
Attachment | Size |
---|---|
Handout 12-5-20 (approved).pdf | 361.31 KB |
Schedule
Saturday, Dec. 5
10 a.m. Welcome Ramon Bataller, MD, PhD, Chief of Hepatology, UPMC Center for Liver Diseases Naudia Jonassaint, MD, MHS, Medical Director, UPMC Center for Liver Diseases
10:05 a.m. Session I: Moderator: Kapil Chopra, MD, Vice Chair of Medicine, UPMC Mercy
11:45 a.m. Break and Online Exhibits
12:15 p.m. Session II:Moderator: Obaid Shaikh, MD, Director, Transplant Medicine, VA Pittsburgh Healthcare System
12:15 p.m. COVID-19 and the Liver Naudia Jonassaint, MD, MHS, Medical Director, UPMC Center for Liver Diseases
1:15 p.m. Open Discussion and Q&AModerator: Ramon Bataller, MD, PhD
1:30 p.m. Adjourn Accredited Symposia
Continuing Education Credit
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Health Care Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 3.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 3.25 Attendance
To register, visit: https://services.choruscall.com/links/upmc201205/
Free registration for all attendees.